Fiche société
PepGen Inc
Traitements, essais et publications liés.
Traitements2programmes
Essais1liés
Publications0liées
SourceDBlocale
Traitements
2| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| PGN-EDODM1The purpose of this study is to learn about the effects of an investigational medicine, PGN-EDODM1, to see how safe and tolerable multiple administrations of PGN-EDODM1 are for people with myotonic dystrophy type 1 (DM1) compared to placebo. | Myopathies | Phase 2 | À vérifier | Canada, New Zealand, South Korea, United Kingdom | À vérifier |
| PGN-EDODM1The purpose of this study is to learn about the effects of an investigational medicine, PGN-EDODM1, to see how safe and tolerable multiple administrations of PGN-EDODM1 are for people with myotonic dystrophy type 1 (DM1) compared to placebo. | Myopathies | Phase 2 | À vérifier | Canada, New Zealand, South Korea, United Kingdom | À vérifier |
Essais cliniques
1| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| PGN-EDODM1 | Myopathies | Phase 2 | NCT06667453 | FREEDOM2-DM1 — A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1 | RECRUITING |
Publications
0| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| Aucune publication. | ||||